Day: April 26, 2022

Bank of Åland Plc: Interim Report for the period January – March 2022

Written by Customer Service on April 26, 2022. Posted in Earnings Releases And Operating Results.

Bank of Åland PlcInterim ReportApril 26, 2022 9.00 am Interim Report for the period January – March 2022 “The quarter included major macroeconomic events, with rising interest rates and bond yields as well as falling stock markets due to mounting inflation and Russia’s invasion of Ukraine. “One major change for the Bank of Åland was the divestment of most of our Swedish mortgage loan portfolio (SEK 10.4 billion) to the mortgage company Borgo, in which the Bank of Åland is one of the main shareholders. As communicated earlier, this divestment provided a nonrecurring income of EUR 9.8 M. The diminished loan portfolio lowers our net interest income but will generate income from distribution and management of Borgo’s mortgage loans. “Despite market volatility during the quarter, we saw a continued net inflow to our investment services...

Innofactor Plc’s Interim Report for January 1–March 31, 2022 (IFRS)

Written by Customer Service on April 26, 2022. Posted in Earnings Releases And Operating Results.

Innofactor Plc Interim Report April 26, 2022, at 9:00 Finnish time The absences due to sickness arising from the COVID-19 pandemic made the first quarter challenging – with the net sales and operative operating margin slightly smaller than the previous year January–March 2022 in brief:Net sales were approximately EUR 17.0 million (2021: 17.8), representing a decrease of 4.7%The net sales of 2021 include the net sales of the sold Prime business (EUR 0.6 million), without which the comparable change would have represented a decrease of 1.5%Operating margin was approximately EUR 2.0 million (2021: 4.7), representing a decrease of 56.2%The operating margin of 2021 includes a sales gain of approximately EUR 2.6 million from the sale of the Prime business, without which the comparable change of the operating margin would have represented...

Proactive news headlines including Cooper Metals, Oar Resources, Magnis Energy Technologies and International Graphite

Written by Customer Service on April 26, 2022. Posted in Mergers And Acquisitions.

Sydney, April 26, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Cooper Metals Ltd (ASX:CPM) has secured a contract for 20 holes and 2,000 metres of reverse circulation drilling at King Solomon and Python prospects of the Mt Isa East Copper-Gold Project in northwest Queensland, part of an expansive exploration effort which will include a large airborne versatile domain electromagnetic (VTEM) survey. Click here Oar Resources Ltd (ASX:OAR) has identified an opportunity to put its Oakdale Graphite Project back on the map following a detailed assessment of the Eyre Peninsula, South Australia based project. Click here Magnis Energy Technologies Ltd (ASX:MNS, OTCQX:MNSEF) subsidiary Imperium3 New York (iM3NY) continues to...

Tryg A/S – Q1 report 2022

Written by Customer Service on April 26, 2022. Posted in Earnings Releases And Operating Results.

Tryg’s Supervisory Board has today approved the interim report for Q1 2022.Tryg stand-alone reported a premium growth of 5.1% (6.2% in Q1 2021) primarily driven by the Private and Commercial segments, a highest ever Q1 technical result of DKK 754m (DKK 751m) which was positively impacted by a positive top-line growth, improved underlying business, but partly offset by higher large and weather claims compared to the prior-year period. The new Swedish business, Trygg-Hansa, whose results are booked under the investment income for the last time, has reported a premiums growth of approximately 3% and a highly satisfactory technical result of DKK 621m, driven by a combined ratio of 73.3, and a slightly improving underlying performance. The investment result of DKK -284m included Tryg stand-alone investment result (DKK -124m) and the income...

Press release Orange : Q1 2022 results – Revenue growth and improved EBITDAaL margin

Written by Customer Service on April 26, 2022. Posted in Earnings Releases And Operating Results.

Press releaseParis, 26 April 2022 Financial information at 31 March 2022 Revenue growth and improved EBITDAaL marginRetail services reap full benefits of value strategy and improved customer experienceIn millions of euros 1Q 2022 1Q 2021comparablebasis 1Q 2021historicalbasis changecomparablebasis changehistoricalbasisRevenues 10,582 10,511 10,315 0.7 % 2.6 %EBITDAaL 2,620 2,595 2,565 1.0 % 2.2 %eCAPEX (excluding licenses) 1,610 1,708 1,760 (5.8)% (8.6)%EBITDAaL – eCAPEX 1,011 887 805 13.9 % 25.6 %Revenues rose 0.7%1 in the first quarter, driven by Africa & Middle East (+8.7%). Growth in retail services was well above the decline in Wholesale services.In France, the faster pace of retail services growth has yet to offset the decline in Wholesale. Revenues fell slightly, by 0.7%. Revenues in...

Valneva Announces Upsized Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed

Written by Customer Service on April 26, 2022. Posted in Public Companies.

Up to an additional $40 million made available as part of the agreementSaint–Herblain (France), April 26, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an agreement to increase the principal amount of its existing $60 million debt financing agreement with funds managed by leading US-based healthcare investment firms Deerfield Management Company and OrbiMed. This extension will provide Valneva immediate access to $20 million, with an additional $20 million available upon potential conditional approval of its inactivated COVID-19 vaccine candidate, VLA2001, by the European Medicines Agency. The increased funding will be used to further invest in R&D, including market access preparations for Valneva’s chikungunya vaccine candidate, VLA1553. Peter Bühler, Chief Financial Officer...

Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate

Written by Customer Service on April 26, 2022. Posted in Public Companies.

Strong immunogenicity profile observed in study participants aged 5-17 years one month after the primary vaccination series Safety profile observed in pediatric participants similar to previously reported data in adult participants Pediatric population to be included in planned Phase 3 trial – expected to start in Q3 2022, subject to regulatory approvalSaint-Herblain (France) and New York, April 26, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported positive Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15. Based on these new results, Valneva and Pfizer plan to proceed with inclusion of pediatric participants in their planned Phase 3 trial. The trial will evaluate VLA15 in adults and pediatric subjects 5 years of age and above and is expected...

eQ Plc’s interim report Q1 2022 – eQ’s year started off excellently

Written by Customer Service on April 26, 2022. Posted in Earnings Releases And Operating Results.

eQ Plc interim report26 April 2022 at 8:00 AM January to March 2022 in briefThe Group’s net revenue during the period was EUR 21.7 million (EUR 18.0 million from 1 Jan. to 31 March 2021). The Group’s net fee and commission income was EUR 21.4 million (EUR 15.8 million). The Group’s net investment income from own investment operations was EUR 0.3 million (EUR 2.2 million), including the return from private equity and real estate fund investments and liquid fixed income funds. The Group’s operating profit grew by 23% to EUR 13.0 million (EUR 10.6 million). The Group’s profit was EUR 10.3 million (EUR 8.4 million). The consolidated earnings per share were EUR 0.26 (EUR 0.22). The net revenue of the Asset Management segment increased by 32% to EUR 19.6 million (EUR 14.8 million) and the operating profit by 43% to EUR 12.6 million...

Aspocomp’s Interim Report January 1-March 31, 2022: Net sales increased by 45 percent and operating result improved significantly in the first quarter

Written by Customer Service on April 26, 2022. Posted in Earnings Releases And Operating Results.

Aspocomp Group Plc, Interim Report, April 26, 2022 at 8:00 a.m. EEST FIRST QUARTER 2022 HIGHLIGHTSNet sales EUR 9.0 (6.2) million, increase of 45% Operating result EUR 0.8 (-0.5) million, 8.9% (-8.0%) of net sales Earnings per share EUR 0.11 (-0.07) Operative cash flow EUR 0.7 (-0.1) million Equity ratio 66.9% (62.7%), increase of 4% Order book at the end of the review period EUR 20.5 (5.3) million, increase of 284% Orders received EUR 13.0 (8.0) million, increase of 63%OUTLOOK FOR 2022 Demand is expected to improve in all customer segments. However, a global shortage of components may limit growth in customer demand. The company’s full-year guidance remains unchanged. Aspocomp estimates that its net sales for 2022 will increase and its operating result for 2022 will improve from 2021. In 2021, net sales amounted to EUR 33.2...

Forvia Sales Q1 2022

Written by Customer Service on April 26, 2022. Posted in Earnings Releases And Operating Results.

Nanterre (France), April 26, 2022 FIRST-QUARTER 2022 SALESQ1 2022 SALES OF €5.3bn, UP 33% ON A REPORTED BASIS (including first two months of consolidation of HELLA) ORGANIC SALES GROWTH OF +1.1% (Faurecia stand-alone), OUTPERFORMING AUTOMOTIVE PRODUCTION BY 530bps FIRST RELEASE OF FORVIA’S FY 2022 GUIDANCE (including 11 months of consolidation of HELLA) INCREASED FINANCIAL FLEXIBILITY TO GET THROUGH THE CURRENT UNCERTAIN ENVIRONMENT, thanks to covenant renegotiation, suspended dividend payment in 2022 and upgraded asset divestment program by end 2023in €m Q1 2021 Currency effect Organic growth Scope effect (HELLA 2 months) Q1 2022 Reported changeGroup sales 4,005 129 46 1,143 5,322 +32.9%% last year’s sales +3.2% ...

Day: April 26, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice